Genmab — September 2013
-
http://www.managingmyeloma.com/knowledge-center/faq-library/784-what-is-daratumumab-and-if-approved-how-will-it-be-used-to-treat-multiple-myeloma lidt god omtale af dara og lovning af
nye forsøg -
http://www.ncbi.nlm.nih.gov/pubmed/23918228 Der arbejdes stadig med egfr target
-
http://patents.justia.com/inventor/paul-parren Her2 og C-Met kan være nogle af de kommende targets
-
DuoBody tror jeg bestemt er for tidligt i 2014 - håber på 2015, men er ikke sikker ! Hexa er straks sværere at vurdere, for hvis det er boost af et stof der har været i klinik, så kan det gå stærkt, men i 2014 så skal det næsten være et af Genmabs egne og her er det vist Zalutumumab som er eneste bud
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind